Side-by-side financials for CADL and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CADL | RVMD |
|---|---|---|
| Market cap | - | $31.73 B |
| US-listed rank | - | #448 |
| Revenue (latest FY) | $125.00K | $0.00 |
| Net income (latest FY) | -$38.18M | -$1.13B |
| Net margin | -30545.6% | - |
| SEC filings | 382 | 782 |
Full pages: Candel Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.